Global Beta-Nicotinamide Mononucleotide Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Beta-Nicotinamide Mononucleotide Industry Forecast” looks at past sales and reviews total world Beta-Nicotinamide Mononucleotide sales in 2022, providing a comprehensive analysis by region and market sector of projected Beta-Nicotinamide Mononucleotide sales for 2023 through 2029. With Beta-Nicotinamide Mononucleotide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Beta-Nicotinamide Mononucleotide industry.
This Insight Report provides a comprehensive analysis of the global Beta-Nicotinamide Mononucleotide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Beta-Nicotinamide Mononucleotide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Beta-Nicotinamide Mononucleotide market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Beta-Nicotinamide Mononucleotide and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Beta-Nicotinamide Mononucleotide.
The global Beta-Nicotinamide Mononucleotide market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Beta-Nicotinamide Mononucleotide is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Beta-Nicotinamide Mononucleotide is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Beta-Nicotinamide Mononucleotide is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Beta-Nicotinamide Mononucleotide players cover GeneHarbor, Herbalmax, Genex Formulas, Shinkowa Pharmaceutical, Maac10 Formulas, EffePharm, Bontac, CELFULL and Kingdomway, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Beta-Nicotinamide Mononucleotide market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Beta-Nicotinamide Mononucleotide market?
What factors are driving Beta-Nicotinamide Mononucleotide market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Beta-Nicotinamide Mononucleotide market opportunities vary by end market size?
How does Beta-Nicotinamide Mononucleotide break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Beta-Nicotinamide Mononucleotide Industry Forecast” looks at past sales and reviews total world Beta-Nicotinamide Mononucleotide sales in 2022, providing a comprehensive analysis by region and market sector of projected Beta-Nicotinamide Mononucleotide sales for 2023 through 2029. With Beta-Nicotinamide Mononucleotide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Beta-Nicotinamide Mononucleotide industry.
This Insight Report provides a comprehensive analysis of the global Beta-Nicotinamide Mononucleotide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Beta-Nicotinamide Mononucleotide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Beta-Nicotinamide Mononucleotide market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Beta-Nicotinamide Mononucleotide and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Beta-Nicotinamide Mononucleotide.
The global Beta-Nicotinamide Mononucleotide market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Beta-Nicotinamide Mononucleotide is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Beta-Nicotinamide Mononucleotide is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Beta-Nicotinamide Mononucleotide is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Beta-Nicotinamide Mononucleotide players cover GeneHarbor, Herbalmax, Genex Formulas, Shinkowa Pharmaceutical, Maac10 Formulas, EffePharm, Bontac, CELFULL and Kingdomway, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Beta-Nicotinamide Mononucleotide market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Above 98%
- Below 98%
- Health Care Products
- Cosmetics
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GeneHarbor
- Herbalmax
- Genex Formulas
- Shinkowa Pharmaceutical
- Maac10 Formulas
- EffePharm
- Bontac
- CELFULL
- Kingdomway
What is the 10-year outlook for the global Beta-Nicotinamide Mononucleotide market?
What factors are driving Beta-Nicotinamide Mononucleotide market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Beta-Nicotinamide Mononucleotide market opportunities vary by end market size?
How does Beta-Nicotinamide Mononucleotide break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Beta-Nicotinamide Mononucleotide Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Beta-Nicotinamide Mononucleotide by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Beta-Nicotinamide Mononucleotide by Country/Region, 2018, 2022 & 2029
2.2 Beta-Nicotinamide Mononucleotide Segment by Type
2.2.1 Above 98%
2.2.2 Below 98%
2.3 Beta-Nicotinamide Mononucleotide Sales by Type
2.3.1 Global Beta-Nicotinamide Mononucleotide Sales Market Share by Type (2018-2023)
2.3.2 Global Beta-Nicotinamide Mononucleotide Revenue and Market Share by Type (2018-2023)
2.3.3 Global Beta-Nicotinamide Mononucleotide Sale Price by Type (2018-2023)
2.4 Beta-Nicotinamide Mononucleotide Segment by Application
2.4.1 Health Care Products
2.4.2 Cosmetics
2.4.3 Others
2.5 Beta-Nicotinamide Mononucleotide Sales by Application
2.5.1 Global Beta-Nicotinamide Mononucleotide Sale Market Share by Application (2018-2023)
2.5.2 Global Beta-Nicotinamide Mononucleotide Revenue and Market Share by Application (2018-2023)
2.5.3 Global Beta-Nicotinamide Mononucleotide Sale Price by Application (2018-2023)
3 GLOBAL BETA-NICOTINAMIDE MONONUCLEOTIDE BY COMPANY
3.1 Global Beta-Nicotinamide Mononucleotide Breakdown Data by Company
3.1.1 Global Beta-Nicotinamide Mononucleotide Annual Sales by Company (2018-2023)
3.1.2 Global Beta-Nicotinamide Mononucleotide Sales Market Share by Company (2018-2023)
3.2 Global Beta-Nicotinamide Mononucleotide Annual Revenue by Company (2018-2023)
3.2.1 Global Beta-Nicotinamide Mononucleotide Revenue by Company (2018-2023)
3.2.2 Global Beta-Nicotinamide Mononucleotide Revenue Market Share by Company (2018-2023)
3.3 Global Beta-Nicotinamide Mononucleotide Sale Price by Company
3.4 Key Manufacturers Beta-Nicotinamide Mononucleotide Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Beta-Nicotinamide Mononucleotide Product Location Distribution
3.4.2 Players Beta-Nicotinamide Mononucleotide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR BETA-NICOTINAMIDE MONONUCLEOTIDE BY GEOGRAPHIC REGION
4.1 World Historic Beta-Nicotinamide Mononucleotide Market Size by Geographic Region (2018-2023)
4.1.1 Global Beta-Nicotinamide Mononucleotide Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Beta-Nicotinamide Mononucleotide Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Beta-Nicotinamide Mononucleotide Market Size by Country/Region (2018-2023)
4.2.1 Global Beta-Nicotinamide Mononucleotide Annual Sales by Country/Region (2018-2023)
4.2.2 Global Beta-Nicotinamide Mononucleotide Annual Revenue by Country/Region (2018-2023)
4.3 Americas Beta-Nicotinamide Mononucleotide Sales Growth
4.4 APAC Beta-Nicotinamide Mononucleotide Sales Growth
4.5 Europe Beta-Nicotinamide Mononucleotide Sales Growth
4.6 Middle East & Africa Beta-Nicotinamide Mononucleotide Sales Growth
5 AMERICAS
5.1 Americas Beta-Nicotinamide Mononucleotide Sales by Country
5.1.1 Americas Beta-Nicotinamide Mononucleotide Sales by Country (2018-2023)
5.1.2 Americas Beta-Nicotinamide Mononucleotide Revenue by Country (2018-2023)
5.2 Americas Beta-Nicotinamide Mononucleotide Sales by Type
5.3 Americas Beta-Nicotinamide Mononucleotide Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Beta-Nicotinamide Mononucleotide Sales by Region
6.1.1 APAC Beta-Nicotinamide Mononucleotide Sales by Region (2018-2023)
6.1.2 APAC Beta-Nicotinamide Mononucleotide Revenue by Region (2018-2023)
6.2 APAC Beta-Nicotinamide Mononucleotide Sales by Type
6.3 APAC Beta-Nicotinamide Mononucleotide Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Beta-Nicotinamide Mononucleotide by Country
7.1.1 Europe Beta-Nicotinamide Mononucleotide Sales by Country (2018-2023)
7.1.2 Europe Beta-Nicotinamide Mononucleotide Revenue by Country (2018-2023)
7.2 Europe Beta-Nicotinamide Mononucleotide Sales by Type
7.3 Europe Beta-Nicotinamide Mononucleotide Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Beta-Nicotinamide Mononucleotide by Country
8.1.1 Middle East & Africa Beta-Nicotinamide Mononucleotide Sales by Country (2018-2023)
8.1.2 Middle East & Africa Beta-Nicotinamide Mononucleotide Revenue by Country (2018-2023)
8.2 Middle East & Africa Beta-Nicotinamide Mononucleotide Sales by Type
8.3 Middle East & Africa Beta-Nicotinamide Mononucleotide Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Beta-Nicotinamide Mononucleotide
10.3 Manufacturing Process Analysis of Beta-Nicotinamide Mononucleotide
10.4 Industry Chain Structure of Beta-Nicotinamide Mononucleotide
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Beta-Nicotinamide Mononucleotide Distributors
11.3 Beta-Nicotinamide Mononucleotide Customer
12 WORLD FORECAST REVIEW FOR BETA-NICOTINAMIDE MONONUCLEOTIDE BY GEOGRAPHIC REGION
12.1 Global Beta-Nicotinamide Mononucleotide Market Size Forecast by Region
12.1.1 Global Beta-Nicotinamide Mononucleotide Forecast by Region (2024-2029)
12.1.2 Global Beta-Nicotinamide Mononucleotide Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Beta-Nicotinamide Mononucleotide Forecast by Type
12.7 Global Beta-Nicotinamide Mononucleotide Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 GeneHarbor
13.1.1 GeneHarbor Company Information
13.1.2 GeneHarbor Beta-Nicotinamide Mononucleotide Product Portfolios and Specifications
13.1.3 GeneHarbor Beta-Nicotinamide Mononucleotide Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 GeneHarbor Main Business Overview
13.1.5 GeneHarbor Latest Developments
13.2 Herbalmax
13.2.1 Herbalmax Company Information
13.2.2 Herbalmax Beta-Nicotinamide Mononucleotide Product Portfolios and Specifications
13.2.3 Herbalmax Beta-Nicotinamide Mononucleotide Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Herbalmax Main Business Overview
13.2.5 Herbalmax Latest Developments
13.3 Genex Formulas
13.3.1 Genex Formulas Company Information
13.3.2 Genex Formulas Beta-Nicotinamide Mononucleotide Product Portfolios and Specifications
13.3.3 Genex Formulas Beta-Nicotinamide Mononucleotide Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Genex Formulas Main Business Overview
13.3.5 Genex Formulas Latest Developments
13.4 Shinkowa Pharmaceutical
13.4.1 Shinkowa Pharmaceutical Company Information
13.4.2 Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide Product Portfolios and Specifications
13.4.3 Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Shinkowa Pharmaceutical Main Business Overview
13.4.5 Shinkowa Pharmaceutical Latest Developments
13.5 Maac10 Formulas
13.5.1 Maac10 Formulas Company Information
13.5.2 Maac10 Formulas Beta-Nicotinamide Mononucleotide Product Portfolios and Specifications
13.5.3 Maac10 Formulas Beta-Nicotinamide Mononucleotide Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Maac10 Formulas Main Business Overview
13.5.5 Maac10 Formulas Latest Developments
13.6 EffePharm
13.6.1 EffePharm Company Information
13.6.2 EffePharm Beta-Nicotinamide Mononucleotide Product Portfolios and Specifications
13.6.3 EffePharm Beta-Nicotinamide Mononucleotide Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 EffePharm Main Business Overview
13.6.5 EffePharm Latest Developments
13.7 Bontac
13.7.1 Bontac Company Information
13.7.2 Bontac Beta-Nicotinamide Mononucleotide Product Portfolios and Specifications
13.7.3 Bontac Beta-Nicotinamide Mononucleotide Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Bontac Main Business Overview
13.7.5 Bontac Latest Developments
13.8 CELFULL
13.8.1 CELFULL Company Information
13.8.2 CELFULL Beta-Nicotinamide Mononucleotide Product Portfolios and Specifications
13.8.3 CELFULL Beta-Nicotinamide Mononucleotide Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 CELFULL Main Business Overview
13.8.5 CELFULL Latest Developments
13.9 Kingdomway
13.9.1 Kingdomway Company Information
13.9.2 Kingdomway Beta-Nicotinamide Mononucleotide Product Portfolios and Specifications
13.9.3 Kingdomway Beta-Nicotinamide Mononucleotide Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Kingdomway Main Business Overview
13.9.5 Kingdomway Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Beta-Nicotinamide Mononucleotide Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Beta-Nicotinamide Mononucleotide by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Beta-Nicotinamide Mononucleotide by Country/Region, 2018, 2022 & 2029
2.2 Beta-Nicotinamide Mononucleotide Segment by Type
2.2.1 Above 98%
2.2.2 Below 98%
2.3 Beta-Nicotinamide Mononucleotide Sales by Type
2.3.1 Global Beta-Nicotinamide Mononucleotide Sales Market Share by Type (2018-2023)
2.3.2 Global Beta-Nicotinamide Mononucleotide Revenue and Market Share by Type (2018-2023)
2.3.3 Global Beta-Nicotinamide Mononucleotide Sale Price by Type (2018-2023)
2.4 Beta-Nicotinamide Mononucleotide Segment by Application
2.4.1 Health Care Products
2.4.2 Cosmetics
2.4.3 Others
2.5 Beta-Nicotinamide Mononucleotide Sales by Application
2.5.1 Global Beta-Nicotinamide Mononucleotide Sale Market Share by Application (2018-2023)
2.5.2 Global Beta-Nicotinamide Mononucleotide Revenue and Market Share by Application (2018-2023)
2.5.3 Global Beta-Nicotinamide Mononucleotide Sale Price by Application (2018-2023)
3 GLOBAL BETA-NICOTINAMIDE MONONUCLEOTIDE BY COMPANY
3.1 Global Beta-Nicotinamide Mononucleotide Breakdown Data by Company
3.1.1 Global Beta-Nicotinamide Mononucleotide Annual Sales by Company (2018-2023)
3.1.2 Global Beta-Nicotinamide Mononucleotide Sales Market Share by Company (2018-2023)
3.2 Global Beta-Nicotinamide Mononucleotide Annual Revenue by Company (2018-2023)
3.2.1 Global Beta-Nicotinamide Mononucleotide Revenue by Company (2018-2023)
3.2.2 Global Beta-Nicotinamide Mononucleotide Revenue Market Share by Company (2018-2023)
3.3 Global Beta-Nicotinamide Mononucleotide Sale Price by Company
3.4 Key Manufacturers Beta-Nicotinamide Mononucleotide Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Beta-Nicotinamide Mononucleotide Product Location Distribution
3.4.2 Players Beta-Nicotinamide Mononucleotide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR BETA-NICOTINAMIDE MONONUCLEOTIDE BY GEOGRAPHIC REGION
4.1 World Historic Beta-Nicotinamide Mononucleotide Market Size by Geographic Region (2018-2023)
4.1.1 Global Beta-Nicotinamide Mononucleotide Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Beta-Nicotinamide Mononucleotide Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Beta-Nicotinamide Mononucleotide Market Size by Country/Region (2018-2023)
4.2.1 Global Beta-Nicotinamide Mononucleotide Annual Sales by Country/Region (2018-2023)
4.2.2 Global Beta-Nicotinamide Mononucleotide Annual Revenue by Country/Region (2018-2023)
4.3 Americas Beta-Nicotinamide Mononucleotide Sales Growth
4.4 APAC Beta-Nicotinamide Mononucleotide Sales Growth
4.5 Europe Beta-Nicotinamide Mononucleotide Sales Growth
4.6 Middle East & Africa Beta-Nicotinamide Mononucleotide Sales Growth
5 AMERICAS
5.1 Americas Beta-Nicotinamide Mononucleotide Sales by Country
5.1.1 Americas Beta-Nicotinamide Mononucleotide Sales by Country (2018-2023)
5.1.2 Americas Beta-Nicotinamide Mononucleotide Revenue by Country (2018-2023)
5.2 Americas Beta-Nicotinamide Mononucleotide Sales by Type
5.3 Americas Beta-Nicotinamide Mononucleotide Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Beta-Nicotinamide Mononucleotide Sales by Region
6.1.1 APAC Beta-Nicotinamide Mononucleotide Sales by Region (2018-2023)
6.1.2 APAC Beta-Nicotinamide Mononucleotide Revenue by Region (2018-2023)
6.2 APAC Beta-Nicotinamide Mononucleotide Sales by Type
6.3 APAC Beta-Nicotinamide Mononucleotide Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Beta-Nicotinamide Mononucleotide by Country
7.1.1 Europe Beta-Nicotinamide Mononucleotide Sales by Country (2018-2023)
7.1.2 Europe Beta-Nicotinamide Mononucleotide Revenue by Country (2018-2023)
7.2 Europe Beta-Nicotinamide Mononucleotide Sales by Type
7.3 Europe Beta-Nicotinamide Mononucleotide Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Beta-Nicotinamide Mononucleotide by Country
8.1.1 Middle East & Africa Beta-Nicotinamide Mononucleotide Sales by Country (2018-2023)
8.1.2 Middle East & Africa Beta-Nicotinamide Mononucleotide Revenue by Country (2018-2023)
8.2 Middle East & Africa Beta-Nicotinamide Mononucleotide Sales by Type
8.3 Middle East & Africa Beta-Nicotinamide Mononucleotide Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Beta-Nicotinamide Mononucleotide
10.3 Manufacturing Process Analysis of Beta-Nicotinamide Mononucleotide
10.4 Industry Chain Structure of Beta-Nicotinamide Mononucleotide
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Beta-Nicotinamide Mononucleotide Distributors
11.3 Beta-Nicotinamide Mononucleotide Customer
12 WORLD FORECAST REVIEW FOR BETA-NICOTINAMIDE MONONUCLEOTIDE BY GEOGRAPHIC REGION
12.1 Global Beta-Nicotinamide Mononucleotide Market Size Forecast by Region
12.1.1 Global Beta-Nicotinamide Mononucleotide Forecast by Region (2024-2029)
12.1.2 Global Beta-Nicotinamide Mononucleotide Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Beta-Nicotinamide Mononucleotide Forecast by Type
12.7 Global Beta-Nicotinamide Mononucleotide Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 GeneHarbor
13.1.1 GeneHarbor Company Information
13.1.2 GeneHarbor Beta-Nicotinamide Mononucleotide Product Portfolios and Specifications
13.1.3 GeneHarbor Beta-Nicotinamide Mononucleotide Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 GeneHarbor Main Business Overview
13.1.5 GeneHarbor Latest Developments
13.2 Herbalmax
13.2.1 Herbalmax Company Information
13.2.2 Herbalmax Beta-Nicotinamide Mononucleotide Product Portfolios and Specifications
13.2.3 Herbalmax Beta-Nicotinamide Mononucleotide Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Herbalmax Main Business Overview
13.2.5 Herbalmax Latest Developments
13.3 Genex Formulas
13.3.1 Genex Formulas Company Information
13.3.2 Genex Formulas Beta-Nicotinamide Mononucleotide Product Portfolios and Specifications
13.3.3 Genex Formulas Beta-Nicotinamide Mononucleotide Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Genex Formulas Main Business Overview
13.3.5 Genex Formulas Latest Developments
13.4 Shinkowa Pharmaceutical
13.4.1 Shinkowa Pharmaceutical Company Information
13.4.2 Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide Product Portfolios and Specifications
13.4.3 Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Shinkowa Pharmaceutical Main Business Overview
13.4.5 Shinkowa Pharmaceutical Latest Developments
13.5 Maac10 Formulas
13.5.1 Maac10 Formulas Company Information
13.5.2 Maac10 Formulas Beta-Nicotinamide Mononucleotide Product Portfolios and Specifications
13.5.3 Maac10 Formulas Beta-Nicotinamide Mononucleotide Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Maac10 Formulas Main Business Overview
13.5.5 Maac10 Formulas Latest Developments
13.6 EffePharm
13.6.1 EffePharm Company Information
13.6.2 EffePharm Beta-Nicotinamide Mononucleotide Product Portfolios and Specifications
13.6.3 EffePharm Beta-Nicotinamide Mononucleotide Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 EffePharm Main Business Overview
13.6.5 EffePharm Latest Developments
13.7 Bontac
13.7.1 Bontac Company Information
13.7.2 Bontac Beta-Nicotinamide Mononucleotide Product Portfolios and Specifications
13.7.3 Bontac Beta-Nicotinamide Mononucleotide Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Bontac Main Business Overview
13.7.5 Bontac Latest Developments
13.8 CELFULL
13.8.1 CELFULL Company Information
13.8.2 CELFULL Beta-Nicotinamide Mononucleotide Product Portfolios and Specifications
13.8.3 CELFULL Beta-Nicotinamide Mononucleotide Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 CELFULL Main Business Overview
13.8.5 CELFULL Latest Developments
13.9 Kingdomway
13.9.1 Kingdomway Company Information
13.9.2 Kingdomway Beta-Nicotinamide Mononucleotide Product Portfolios and Specifications
13.9.3 Kingdomway Beta-Nicotinamide Mononucleotide Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Kingdomway Main Business Overview
13.9.5 Kingdomway Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Beta-Nicotinamide Mononucleotide Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Beta-Nicotinamide Mononucleotide Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Above 98%
Table 4. Major Players of Below 98%
Table 5. Global Beta-Nicotinamide Mononucleotide Sales by Type (2018-2023) & (Tons)
Table 6. Global Beta-Nicotinamide Mononucleotide Sales Market Share by Type (2018-2023)
Table 7. Global Beta-Nicotinamide Mononucleotide Revenue by Type (2018-2023) & ($ million)
Table 8. Global Beta-Nicotinamide Mononucleotide Revenue Market Share by Type (2018-2023)
Table 9. Global Beta-Nicotinamide Mononucleotide Sale Price by Type (2018-2023) & (US$/Ton)
Table 10. Global Beta-Nicotinamide Mononucleotide Sales by Application (2018-2023) & (Tons)
Table 11. Global Beta-Nicotinamide Mononucleotide Sales Market Share by Application (2018-2023)
Table 12. Global Beta-Nicotinamide Mononucleotide Revenue by Application (2018-2023)
Table 13. Global Beta-Nicotinamide Mononucleotide Revenue Market Share by Application (2018-2023)
Table 14. Global Beta-Nicotinamide Mononucleotide Sale Price by Application (2018-2023) & (US$/Ton)
Table 15. Global Beta-Nicotinamide Mononucleotide Sales by Company (2018-2023) & (Tons)
Table 16. Global Beta-Nicotinamide Mononucleotide Sales Market Share by Company (2018-2023)
Table 17. Global Beta-Nicotinamide Mononucleotide Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Beta-Nicotinamide Mononucleotide Revenue Market Share by Company (2018-2023)
Table 19. Global Beta-Nicotinamide Mononucleotide Sale Price by Company (2018-2023) & (US$/Ton)
Table 20. Key Manufacturers Beta-Nicotinamide Mononucleotide Producing Area Distribution and Sales Area
Table 21. Players Beta-Nicotinamide Mononucleotide Products Offered
Table 22. Beta-Nicotinamide Mononucleotide Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Beta-Nicotinamide Mononucleotide Sales by Geographic Region (2018-2023) & (Tons)
Table 26. Global Beta-Nicotinamide Mononucleotide Sales Market Share Geographic Region (2018-2023)
Table 27. Global Beta-Nicotinamide Mononucleotide Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Beta-Nicotinamide Mononucleotide Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Beta-Nicotinamide Mononucleotide Sales by Country/Region (2018-2023) & (Tons)
Table 30. Global Beta-Nicotinamide Mononucleotide Sales Market Share by Country/Region (2018-2023)
Table 31. Global Beta-Nicotinamide Mononucleotide Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Beta-Nicotinamide Mononucleotide Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Beta-Nicotinamide Mononucleotide Sales by Country (2018-2023) & (Tons)
Table 34. Americas Beta-Nicotinamide Mononucleotide Sales Market Share by Country (2018-2023)
Table 35. Americas Beta-Nicotinamide Mononucleotide Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Beta-Nicotinamide Mononucleotide Revenue Market Share by Country (2018-2023)
Table 37. Americas Beta-Nicotinamide Mononucleotide Sales by Type (2018-2023) & (Tons)
Table 38. Americas Beta-Nicotinamide Mononucleotide Sales by Application (2018-2023) & (Tons)
Table 39. APAC Beta-Nicotinamide Mononucleotide Sales by Region (2018-2023) & (Tons)
Table 40. APAC Beta-Nicotinamide Mononucleotide Sales Market Share by Region (2018-2023)
Table 41. APAC Beta-Nicotinamide Mononucleotide Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Beta-Nicotinamide Mononucleotide Revenue Market Share by Region (2018-2023)
Table 43. APAC Beta-Nicotinamide Mononucleotide Sales by Type (2018-2023) & (Tons)
Table 44. APAC Beta-Nicotinamide Mononucleotide Sales by Application (2018-2023) & (Tons)
Table 45. Europe Beta-Nicotinamide Mononucleotide Sales by Country (2018-2023) & (Tons)
Table 46. Europe Beta-Nicotinamide Mononucleotide Sales Market Share by Country (2018-2023)
Table 47. Europe Beta-Nicotinamide Mononucleotide Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Beta-Nicotinamide Mononucleotide Revenue Market Share by Country (2018-2023)
Table 49. Europe Beta-Nicotinamide Mononucleotide Sales by Type (2018-2023) & (Tons)
Table 50. Europe Beta-Nicotinamide Mononucleotide Sales by Application (2018-2023) & (Tons)
Table 51. Middle East & Africa Beta-Nicotinamide Mononucleotide Sales by Country (2018-2023) & (Tons)
Table 52. Middle East & Africa Beta-Nicotinamide Mononucleotide Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Beta-Nicotinamide Mononucleotide Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Beta-Nicotinamide Mononucleotide Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Beta-Nicotinamide Mononucleotide Sales by Type (2018-2023) & (Tons)
Table 56. Middle East & Africa Beta-Nicotinamide Mononucleotide Sales by Application (2018-2023) & (Tons)
Table 57. Key Market Drivers & Growth Opportunities of Beta-Nicotinamide Mononucleotide
Table 58. Key Market Challenges & Risks of Beta-Nicotinamide Mononucleotide
Table 59. Key Industry Trends of Beta-Nicotinamide Mononucleotide
Table 60. Beta-Nicotinamide Mononucleotide Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Beta-Nicotinamide Mononucleotide Distributors List
Table 63. Beta-Nicotinamide Mononucleotide Customer List
Table 64. Global Beta-Nicotinamide Mononucleotide Sales Forecast by Region (2024-2029) & (Tons)
Table 65. Global Beta-Nicotinamide Mononucleotide Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Beta-Nicotinamide Mononucleotide Sales Forecast by Country (2024-2029) & (Tons)
Table 67. Americas Beta-Nicotinamide Mononucleotide Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Beta-Nicotinamide Mononucleotide Sales Forecast by Region (2024-2029) & (Tons)
Table 69. APAC Beta-Nicotinamide Mononucleotide Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Beta-Nicotinamide Mononucleotide Sales Forecast by Country (2024-2029) & (Tons)
Table 71. Europe Beta-Nicotinamide Mononucleotide Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Beta-Nicotinamide Mononucleotide Sales Forecast by Country (2024-2029) & (Tons)
Table 73. Middle East & Africa Beta-Nicotinamide Mononucleotide Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Beta-Nicotinamide Mononucleotide Sales Forecast by Type (2024-2029) & (Tons)
Table 75. Global Beta-Nicotinamide Mononucleotide Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Beta-Nicotinamide Mononucleotide Sales Forecast by Application (2024-2029) & (Tons)
Table 77. Global Beta-Nicotinamide Mononucleotide Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. GeneHarbor Basic Information, Beta-Nicotinamide Mononucleotide Manufacturing Base, Sales Area and Its Competitors
Table 79. GeneHarbor Beta-Nicotinamide Mononucleotide Product Portfolios and Specifications
Table 80. GeneHarbor Beta-Nicotinamide Mononucleotide Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 81. GeneHarbor Main Business
Table 82. GeneHarbor Latest Developments
Table 83. Herbalmax Basic Information, Beta-Nicotinamide Mononucleotide Manufacturing Base, Sales Area and Its Competitors
Table 84. Herbalmax Beta-Nicotinamide Mononucleotide Product Portfolios and Specifications
Table 85. Herbalmax Beta-Nicotinamide Mononucleotide Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 86. Herbalmax Main Business
Table 87. Herbalmax Latest Developments
Table 88. Genex Formulas Basic Information, Beta-Nicotinamide Mononucleotide Manufacturing Base, Sales Area and Its Competitors
Table 89. Genex Formulas Beta-Nicotinamide Mononucleotide Product Portfolios and Specifications
Table 90. Genex Formulas Beta-Nicotinamide Mononucleotide Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 91. Genex Formulas Main Business
Table 92. Genex Formulas Latest Developments
Table 93. Shinkowa Pharmaceutical Basic Information, Beta-Nicotinamide Mononucleotide Manufacturing Base, Sales Area and Its Competitors
Table 94. Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide Product Portfolios and Specifications
Table 95. Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 96. Shinkowa Pharmaceutical Main Business
Table 97. Shinkowa Pharmaceutical Latest Developments
Table 98. Maac10 Formulas Basic Information, Beta-Nicotinamide Mononucleotide Manufacturing Base, Sales Area and Its Competitors
Table 99. Maac10 Formulas Beta-Nicotinamide Mononucleotide Product Portfolios and Specifications
Table 100. Maac10 Formulas Beta-Nicotinamide Mononucleotide Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 101. Maac10 Formulas Main Business
Table 102. Maac10 Formulas Latest Developments
Table 103. EffePharm Basic Information, Beta-Nicotinamide Mononucleotide Manufacturing Base, Sales Area and Its Competitors
Table 104. EffePharm Beta-Nicotinamide Mononucleotide Product Portfolios and Specifications
Table 105. EffePharm Beta-Nicotinamide Mononucleotide Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 106. EffePharm Main Business
Table 107. EffePharm Latest Developments
Table 108. Bontac Basic Information, Beta-Nicotinamide Mononucleotide Manufacturing Base, Sales Area and Its Competitors
Table 109. Bontac Beta-Nicotinamide Mononucleotide Product Portfolios and Specifications
Table 110. Bontac Beta-Nicotinamide Mononucleotide Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 111. Bontac Main Business
Table 112. Bontac Latest Developments
Table 113. CELFULL Basic Information, Beta-Nicotinamide Mononucleotide Manufacturing Base, Sales Area and Its Competitors
Table 114. CELFULL Beta-Nicotinamide Mononucleotide Product Portfolios and Specifications
Table 115. CELFULL Beta-Nicotinamide Mononucleotide Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 116. CELFULL Main Business
Table 117. CELFULL Latest Developments
Table 118. Kingdomway Basic Information, Beta-Nicotinamide Mononucleotide Manufacturing Base, Sales Area and Its Competitors
Table 119. Kingdomway Beta-Nicotinamide Mononucleotide Product Portfolios and Specifications
Table 120. Kingdomway Beta-Nicotinamide Mononucleotide Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 121. Kingdomway Main Business
Table 122. Kingdomway Latest Developments
Table 1. Beta-Nicotinamide Mononucleotide Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Beta-Nicotinamide Mononucleotide Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Above 98%
Table 4. Major Players of Below 98%
Table 5. Global Beta-Nicotinamide Mononucleotide Sales by Type (2018-2023) & (Tons)
Table 6. Global Beta-Nicotinamide Mononucleotide Sales Market Share by Type (2018-2023)
Table 7. Global Beta-Nicotinamide Mononucleotide Revenue by Type (2018-2023) & ($ million)
Table 8. Global Beta-Nicotinamide Mononucleotide Revenue Market Share by Type (2018-2023)
Table 9. Global Beta-Nicotinamide Mononucleotide Sale Price by Type (2018-2023) & (US$/Ton)
Table 10. Global Beta-Nicotinamide Mononucleotide Sales by Application (2018-2023) & (Tons)
Table 11. Global Beta-Nicotinamide Mononucleotide Sales Market Share by Application (2018-2023)
Table 12. Global Beta-Nicotinamide Mononucleotide Revenue by Application (2018-2023)
Table 13. Global Beta-Nicotinamide Mononucleotide Revenue Market Share by Application (2018-2023)
Table 14. Global Beta-Nicotinamide Mononucleotide Sale Price by Application (2018-2023) & (US$/Ton)
Table 15. Global Beta-Nicotinamide Mononucleotide Sales by Company (2018-2023) & (Tons)
Table 16. Global Beta-Nicotinamide Mononucleotide Sales Market Share by Company (2018-2023)
Table 17. Global Beta-Nicotinamide Mononucleotide Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Beta-Nicotinamide Mononucleotide Revenue Market Share by Company (2018-2023)
Table 19. Global Beta-Nicotinamide Mononucleotide Sale Price by Company (2018-2023) & (US$/Ton)
Table 20. Key Manufacturers Beta-Nicotinamide Mononucleotide Producing Area Distribution and Sales Area
Table 21. Players Beta-Nicotinamide Mononucleotide Products Offered
Table 22. Beta-Nicotinamide Mononucleotide Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Beta-Nicotinamide Mononucleotide Sales by Geographic Region (2018-2023) & (Tons)
Table 26. Global Beta-Nicotinamide Mononucleotide Sales Market Share Geographic Region (2018-2023)
Table 27. Global Beta-Nicotinamide Mononucleotide Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Beta-Nicotinamide Mononucleotide Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Beta-Nicotinamide Mononucleotide Sales by Country/Region (2018-2023) & (Tons)
Table 30. Global Beta-Nicotinamide Mononucleotide Sales Market Share by Country/Region (2018-2023)
Table 31. Global Beta-Nicotinamide Mononucleotide Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Beta-Nicotinamide Mononucleotide Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Beta-Nicotinamide Mononucleotide Sales by Country (2018-2023) & (Tons)
Table 34. Americas Beta-Nicotinamide Mononucleotide Sales Market Share by Country (2018-2023)
Table 35. Americas Beta-Nicotinamide Mononucleotide Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Beta-Nicotinamide Mononucleotide Revenue Market Share by Country (2018-2023)
Table 37. Americas Beta-Nicotinamide Mononucleotide Sales by Type (2018-2023) & (Tons)
Table 38. Americas Beta-Nicotinamide Mononucleotide Sales by Application (2018-2023) & (Tons)
Table 39. APAC Beta-Nicotinamide Mononucleotide Sales by Region (2018-2023) & (Tons)
Table 40. APAC Beta-Nicotinamide Mononucleotide Sales Market Share by Region (2018-2023)
Table 41. APAC Beta-Nicotinamide Mononucleotide Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Beta-Nicotinamide Mononucleotide Revenue Market Share by Region (2018-2023)
Table 43. APAC Beta-Nicotinamide Mononucleotide Sales by Type (2018-2023) & (Tons)
Table 44. APAC Beta-Nicotinamide Mononucleotide Sales by Application (2018-2023) & (Tons)
Table 45. Europe Beta-Nicotinamide Mononucleotide Sales by Country (2018-2023) & (Tons)
Table 46. Europe Beta-Nicotinamide Mononucleotide Sales Market Share by Country (2018-2023)
Table 47. Europe Beta-Nicotinamide Mononucleotide Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Beta-Nicotinamide Mononucleotide Revenue Market Share by Country (2018-2023)
Table 49. Europe Beta-Nicotinamide Mononucleotide Sales by Type (2018-2023) & (Tons)
Table 50. Europe Beta-Nicotinamide Mononucleotide Sales by Application (2018-2023) & (Tons)
Table 51. Middle East & Africa Beta-Nicotinamide Mononucleotide Sales by Country (2018-2023) & (Tons)
Table 52. Middle East & Africa Beta-Nicotinamide Mononucleotide Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Beta-Nicotinamide Mononucleotide Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Beta-Nicotinamide Mononucleotide Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Beta-Nicotinamide Mononucleotide Sales by Type (2018-2023) & (Tons)
Table 56. Middle East & Africa Beta-Nicotinamide Mononucleotide Sales by Application (2018-2023) & (Tons)
Table 57. Key Market Drivers & Growth Opportunities of Beta-Nicotinamide Mononucleotide
Table 58. Key Market Challenges & Risks of Beta-Nicotinamide Mononucleotide
Table 59. Key Industry Trends of Beta-Nicotinamide Mononucleotide
Table 60. Beta-Nicotinamide Mononucleotide Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Beta-Nicotinamide Mononucleotide Distributors List
Table 63. Beta-Nicotinamide Mononucleotide Customer List
Table 64. Global Beta-Nicotinamide Mononucleotide Sales Forecast by Region (2024-2029) & (Tons)
Table 65. Global Beta-Nicotinamide Mononucleotide Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Beta-Nicotinamide Mononucleotide Sales Forecast by Country (2024-2029) & (Tons)
Table 67. Americas Beta-Nicotinamide Mononucleotide Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Beta-Nicotinamide Mononucleotide Sales Forecast by Region (2024-2029) & (Tons)
Table 69. APAC Beta-Nicotinamide Mononucleotide Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Beta-Nicotinamide Mononucleotide Sales Forecast by Country (2024-2029) & (Tons)
Table 71. Europe Beta-Nicotinamide Mononucleotide Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Beta-Nicotinamide Mononucleotide Sales Forecast by Country (2024-2029) & (Tons)
Table 73. Middle East & Africa Beta-Nicotinamide Mononucleotide Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Beta-Nicotinamide Mononucleotide Sales Forecast by Type (2024-2029) & (Tons)
Table 75. Global Beta-Nicotinamide Mononucleotide Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Beta-Nicotinamide Mononucleotide Sales Forecast by Application (2024-2029) & (Tons)
Table 77. Global Beta-Nicotinamide Mononucleotide Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. GeneHarbor Basic Information, Beta-Nicotinamide Mononucleotide Manufacturing Base, Sales Area and Its Competitors
Table 79. GeneHarbor Beta-Nicotinamide Mononucleotide Product Portfolios and Specifications
Table 80. GeneHarbor Beta-Nicotinamide Mononucleotide Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 81. GeneHarbor Main Business
Table 82. GeneHarbor Latest Developments
Table 83. Herbalmax Basic Information, Beta-Nicotinamide Mononucleotide Manufacturing Base, Sales Area and Its Competitors
Table 84. Herbalmax Beta-Nicotinamide Mononucleotide Product Portfolios and Specifications
Table 85. Herbalmax Beta-Nicotinamide Mononucleotide Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 86. Herbalmax Main Business
Table 87. Herbalmax Latest Developments
Table 88. Genex Formulas Basic Information, Beta-Nicotinamide Mononucleotide Manufacturing Base, Sales Area and Its Competitors
Table 89. Genex Formulas Beta-Nicotinamide Mononucleotide Product Portfolios and Specifications
Table 90. Genex Formulas Beta-Nicotinamide Mononucleotide Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 91. Genex Formulas Main Business
Table 92. Genex Formulas Latest Developments
Table 93. Shinkowa Pharmaceutical Basic Information, Beta-Nicotinamide Mononucleotide Manufacturing Base, Sales Area and Its Competitors
Table 94. Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide Product Portfolios and Specifications
Table 95. Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 96. Shinkowa Pharmaceutical Main Business
Table 97. Shinkowa Pharmaceutical Latest Developments
Table 98. Maac10 Formulas Basic Information, Beta-Nicotinamide Mononucleotide Manufacturing Base, Sales Area and Its Competitors
Table 99. Maac10 Formulas Beta-Nicotinamide Mononucleotide Product Portfolios and Specifications
Table 100. Maac10 Formulas Beta-Nicotinamide Mononucleotide Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 101. Maac10 Formulas Main Business
Table 102. Maac10 Formulas Latest Developments
Table 103. EffePharm Basic Information, Beta-Nicotinamide Mononucleotide Manufacturing Base, Sales Area and Its Competitors
Table 104. EffePharm Beta-Nicotinamide Mononucleotide Product Portfolios and Specifications
Table 105. EffePharm Beta-Nicotinamide Mononucleotide Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 106. EffePharm Main Business
Table 107. EffePharm Latest Developments
Table 108. Bontac Basic Information, Beta-Nicotinamide Mononucleotide Manufacturing Base, Sales Area and Its Competitors
Table 109. Bontac Beta-Nicotinamide Mononucleotide Product Portfolios and Specifications
Table 110. Bontac Beta-Nicotinamide Mononucleotide Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 111. Bontac Main Business
Table 112. Bontac Latest Developments
Table 113. CELFULL Basic Information, Beta-Nicotinamide Mononucleotide Manufacturing Base, Sales Area and Its Competitors
Table 114. CELFULL Beta-Nicotinamide Mononucleotide Product Portfolios and Specifications
Table 115. CELFULL Beta-Nicotinamide Mononucleotide Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 116. CELFULL Main Business
Table 117. CELFULL Latest Developments
Table 118. Kingdomway Basic Information, Beta-Nicotinamide Mononucleotide Manufacturing Base, Sales Area and Its Competitors
Table 119. Kingdomway Beta-Nicotinamide Mononucleotide Product Portfolios and Specifications
Table 120. Kingdomway Beta-Nicotinamide Mononucleotide Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 121. Kingdomway Main Business
Table 122. Kingdomway Latest Developments
LIST OF FIGURES
Figure 1. Picture of Beta-Nicotinamide Mononucleotide
Figure 2. Beta-Nicotinamide Mononucleotide Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Beta-Nicotinamide Mononucleotide Sales Growth Rate 2018-2029 (Tons)
Figure 7. Global Beta-Nicotinamide Mononucleotide Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Beta-Nicotinamide Mononucleotide Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Above 98%
Figure 10. Product Picture of Below 98%
Figure 11. Global Beta-Nicotinamide Mononucleotide Sales Market Share by Type in 2022
Figure 12. Global Beta-Nicotinamide Mononucleotide Revenue Market Share by Type (2018-2023)
Figure 13. Beta-Nicotinamide Mononucleotide Consumed in Health Care Products
Figure 14. Global Beta-Nicotinamide Mononucleotide Market: Health Care Products (2018-2023) & (Tons)
Figure 15. Beta-Nicotinamide Mononucleotide Consumed in Cosmetics
Figure 16. Global Beta-Nicotinamide Mononucleotide Market: Cosmetics (2018-2023) & (Tons)
Figure 17. Beta-Nicotinamide Mononucleotide Consumed in Others
Figure 18. Global Beta-Nicotinamide Mononucleotide Market: Others (2018-2023) & (Tons)
Figure 19. Global Beta-Nicotinamide Mononucleotide Sales Market Share by Application (2022)
Figure 20. Global Beta-Nicotinamide Mononucleotide Revenue Market Share by Application in 2022
Figure 21. Beta-Nicotinamide Mononucleotide Sales Market by Company in 2022 (Tons)
Figure 22. Global Beta-Nicotinamide Mononucleotide Sales Market Share by Company in 2022
Figure 23. Beta-Nicotinamide Mononucleotide Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Beta-Nicotinamide Mononucleotide Revenue Market Share by Company in 2022
Figure 25. Global Beta-Nicotinamide Mononucleotide Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Beta-Nicotinamide Mononucleotide Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Beta-Nicotinamide Mononucleotide Sales 2018-2023 (Tons)
Figure 28. Americas Beta-Nicotinamide Mononucleotide Revenue 2018-2023 ($ Millions)
Figure 29. APAC Beta-Nicotinamide Mononucleotide Sales 2018-2023 (Tons)
Figure 30. APAC Beta-Nicotinamide Mononucleotide Revenue 2018-2023 ($ Millions)
Figure 31. Europe Beta-Nicotinamide Mononucleotide Sales 2018-2023 (Tons)
Figure 32. Europe Beta-Nicotinamide Mononucleotide Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Beta-Nicotinamide Mononucleotide Sales 2018-2023 (Tons)
Figure 34. Middle East & Africa Beta-Nicotinamide Mononucleotide Revenue 2018-2023 ($ Millions)
Figure 35. Americas Beta-Nicotinamide Mononucleotide Sales Market Share by Country in 2022
Figure 36. Americas Beta-Nicotinamide Mononucleotide Revenue Market Share by Country in 2022
Figure 37. Americas Beta-Nicotinamide Mononucleotide Sales Market Share by Type (2018-2023)
Figure 38. Americas Beta-Nicotinamide Mononucleotide Sales Market Share by Application (2018-2023)
Figure 39. United States Beta-Nicotinamide Mononucleotide Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Beta-Nicotinamide Mononucleotide Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Beta-Nicotinamide Mononucleotide Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Beta-Nicotinamide Mononucleotide Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Beta-Nicotinamide Mononucleotide Sales Market Share by Region in 2022
Figure 44. APAC Beta-Nicotinamide Mononucleotide Revenue Market Share by Regions in 2022
Figure 45. APAC Beta-Nicotinamide Mononucleotide Sales Market Share by Type (2018-2023)
Figure 46. APAC Beta-Nicotinamide Mononucleotide Sales Market Share by Application (2018-2023)
Figure 47. China Beta-Nicotinamide Mononucleotide Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Beta-Nicotinamide Mononucleotide Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Beta-Nicotinamide Mononucleotide Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Beta-Nicotinamide Mononucleotide Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Beta-Nicotinamide Mononucleotide Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Beta-Nicotinamide Mononucleotide Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Beta-Nicotinamide Mononucleotide Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Beta-Nicotinamide Mononucleotide Sales Market Share by Country in 2022
Figure 55. Europe Beta-Nicotinamide Mononucleotide Revenue Market Share by Country in 2022
Figure 56. Europe Beta-Nicotinamide Mononucleotide Sales Market Share by Type (2018-2023)
Figure 57. Europe Beta-Nicotinamide Mononucleotide Sales Market Share by Application (2018-2023)
Figure 58. Germany Beta-Nicotinamide Mononucleotide Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Beta-Nicotinamide Mononucleotide Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Beta-Nicotinamide Mononucleotide Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Beta-Nicotinamide Mononucleotide Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Beta-Nicotinamide Mononucleotide Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Beta-Nicotinamide Mononucleotide Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Beta-Nicotinamide Mononucleotide Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Beta-Nicotinamide Mononucleotide Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Beta-Nicotinamide Mononucleotide Sales Market Share by Application (2018-2023)
Figure 67. Egypt Beta-Nicotinamide Mononucleotide Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Beta-Nicotinamide Mononucleotide Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Beta-Nicotinamide Mononucleotide Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Beta-Nicotinamide Mononucleotide Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Beta-Nicotinamide Mononucleotide Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Beta-Nicotinamide Mononucleotide in 2022
Figure 73. Manufacturing Process Analysis of Beta-Nicotinamide Mononucleotide
Figure 74. Industry Chain Structure of Beta-Nicotinamide Mononucleotide
Figure 75. Channels of Distribution
Figure 76. Global Beta-Nicotinamide Mononucleotide Sales Market Forecast by Region (2024-2029)
Figure 77. Global Beta-Nicotinamide Mononucleotide Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Beta-Nicotinamide Mononucleotide Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Beta-Nicotinamide Mononucleotide Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Beta-Nicotinamide Mononucleotide Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Beta-Nicotinamide Mononucleotide Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Beta-Nicotinamide Mononucleotide
Figure 2. Beta-Nicotinamide Mononucleotide Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Beta-Nicotinamide Mononucleotide Sales Growth Rate 2018-2029 (Tons)
Figure 7. Global Beta-Nicotinamide Mononucleotide Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Beta-Nicotinamide Mononucleotide Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Above 98%
Figure 10. Product Picture of Below 98%
Figure 11. Global Beta-Nicotinamide Mononucleotide Sales Market Share by Type in 2022
Figure 12. Global Beta-Nicotinamide Mononucleotide Revenue Market Share by Type (2018-2023)
Figure 13. Beta-Nicotinamide Mononucleotide Consumed in Health Care Products
Figure 14. Global Beta-Nicotinamide Mononucleotide Market: Health Care Products (2018-2023) & (Tons)
Figure 15. Beta-Nicotinamide Mononucleotide Consumed in Cosmetics
Figure 16. Global Beta-Nicotinamide Mononucleotide Market: Cosmetics (2018-2023) & (Tons)
Figure 17. Beta-Nicotinamide Mononucleotide Consumed in Others
Figure 18. Global Beta-Nicotinamide Mononucleotide Market: Others (2018-2023) & (Tons)
Figure 19. Global Beta-Nicotinamide Mononucleotide Sales Market Share by Application (2022)
Figure 20. Global Beta-Nicotinamide Mononucleotide Revenue Market Share by Application in 2022
Figure 21. Beta-Nicotinamide Mononucleotide Sales Market by Company in 2022 (Tons)
Figure 22. Global Beta-Nicotinamide Mononucleotide Sales Market Share by Company in 2022
Figure 23. Beta-Nicotinamide Mononucleotide Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Beta-Nicotinamide Mononucleotide Revenue Market Share by Company in 2022
Figure 25. Global Beta-Nicotinamide Mononucleotide Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Beta-Nicotinamide Mononucleotide Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Beta-Nicotinamide Mononucleotide Sales 2018-2023 (Tons)
Figure 28. Americas Beta-Nicotinamide Mononucleotide Revenue 2018-2023 ($ Millions)
Figure 29. APAC Beta-Nicotinamide Mononucleotide Sales 2018-2023 (Tons)
Figure 30. APAC Beta-Nicotinamide Mononucleotide Revenue 2018-2023 ($ Millions)
Figure 31. Europe Beta-Nicotinamide Mononucleotide Sales 2018-2023 (Tons)
Figure 32. Europe Beta-Nicotinamide Mononucleotide Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Beta-Nicotinamide Mononucleotide Sales 2018-2023 (Tons)
Figure 34. Middle East & Africa Beta-Nicotinamide Mononucleotide Revenue 2018-2023 ($ Millions)
Figure 35. Americas Beta-Nicotinamide Mononucleotide Sales Market Share by Country in 2022
Figure 36. Americas Beta-Nicotinamide Mononucleotide Revenue Market Share by Country in 2022
Figure 37. Americas Beta-Nicotinamide Mononucleotide Sales Market Share by Type (2018-2023)
Figure 38. Americas Beta-Nicotinamide Mononucleotide Sales Market Share by Application (2018-2023)
Figure 39. United States Beta-Nicotinamide Mononucleotide Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Beta-Nicotinamide Mononucleotide Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Beta-Nicotinamide Mononucleotide Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Beta-Nicotinamide Mononucleotide Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Beta-Nicotinamide Mononucleotide Sales Market Share by Region in 2022
Figure 44. APAC Beta-Nicotinamide Mononucleotide Revenue Market Share by Regions in 2022
Figure 45. APAC Beta-Nicotinamide Mononucleotide Sales Market Share by Type (2018-2023)
Figure 46. APAC Beta-Nicotinamide Mononucleotide Sales Market Share by Application (2018-2023)
Figure 47. China Beta-Nicotinamide Mononucleotide Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Beta-Nicotinamide Mononucleotide Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Beta-Nicotinamide Mononucleotide Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Beta-Nicotinamide Mononucleotide Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Beta-Nicotinamide Mononucleotide Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Beta-Nicotinamide Mononucleotide Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Beta-Nicotinamide Mononucleotide Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Beta-Nicotinamide Mononucleotide Sales Market Share by Country in 2022
Figure 55. Europe Beta-Nicotinamide Mononucleotide Revenue Market Share by Country in 2022
Figure 56. Europe Beta-Nicotinamide Mononucleotide Sales Market Share by Type (2018-2023)
Figure 57. Europe Beta-Nicotinamide Mononucleotide Sales Market Share by Application (2018-2023)
Figure 58. Germany Beta-Nicotinamide Mononucleotide Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Beta-Nicotinamide Mononucleotide Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Beta-Nicotinamide Mononucleotide Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Beta-Nicotinamide Mononucleotide Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Beta-Nicotinamide Mononucleotide Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Beta-Nicotinamide Mononucleotide Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Beta-Nicotinamide Mononucleotide Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Beta-Nicotinamide Mononucleotide Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Beta-Nicotinamide Mononucleotide Sales Market Share by Application (2018-2023)
Figure 67. Egypt Beta-Nicotinamide Mononucleotide Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Beta-Nicotinamide Mononucleotide Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Beta-Nicotinamide Mononucleotide Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Beta-Nicotinamide Mononucleotide Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Beta-Nicotinamide Mononucleotide Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Beta-Nicotinamide Mononucleotide in 2022
Figure 73. Manufacturing Process Analysis of Beta-Nicotinamide Mononucleotide
Figure 74. Industry Chain Structure of Beta-Nicotinamide Mononucleotide
Figure 75. Channels of Distribution
Figure 76. Global Beta-Nicotinamide Mononucleotide Sales Market Forecast by Region (2024-2029)
Figure 77. Global Beta-Nicotinamide Mononucleotide Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Beta-Nicotinamide Mononucleotide Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Beta-Nicotinamide Mononucleotide Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Beta-Nicotinamide Mononucleotide Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Beta-Nicotinamide Mononucleotide Revenue Market Share Forecast by Application (2024-2029)
